Zoetis Reports Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Zoetis (ZTS) PT Lifted to $58 at Piper Jaffray on Solid Q3 and Ahead of Simparica Approval
November 4, 2015 8:52 AM ESTPiper Jaffray analyst Kevin Ellich reiterated an Overweight rating and boosted his price target on Zoetis Inc. (NYSE: ZTS) to $58.00 (from $55.00) following solid Q3 results. The analyst sees Simparica approval coming soon.
Ellich commented, "ZTS' Q3 results were impressive as the company... More
Zoetis (ZTS) Announces 3Q Beat and Raise Along with PHARMAQ Deal; Guggenheim Reiterates Buy
November 3, 2015 1:17 PM ESTGuggenheim reiterated a Buy rating and $60.00 price target on Zoetis Inc. (NYSE: ZTS) following the company's 3Q15 earnings results. ZTS reported 3Q15 EPS of $0.50, $0.10 higher than consensus, and then increased its '15 and '16 EPS guidance to $1.70-$1.74 from $1.63-$1.68 and $1.84-$1.94 from $1.81-$1.93, respectively. The release also included the announcement of a deal with PHARMAQ. Management stated that PHARMAQ... More
Zoetis (ZTS) Tops Q3 EPS by 10c; Issues Solid Outlook
November 3, 2015 7:08 AM ESTZoetis (NYSE: ZTS) reported Q3 EPS of $0.50, $0.10 better than the analyst estimate of $0.40. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.18 billion.
Zoetis sees FY2015 EPS of $1.70-$1.74, versus the consensus of $1.66. Zoetis sees FY2015 revenue of $4.7-4.75 billion, versus the consensus of $4.76 billion.
Zoetis sees FY2016 EPS of $1.84-$1.94, versus the consensus of $1.90. Zoetis sees FY2016 revenue of $4.75-4.875 billion, versus the consensus of $4.76 billion.
Zoetis sees FY2017 EPS of... More
